Assessment of laminin-mediated glioma invasion in vitro and by glioma tumors engrafted within rat spinal cord

David Muir, Jennifer Johnson, Mumtaz V Rojiani, Ben A. Inglis, Amyn Mohammed Rojiani, Bernard L. Maria

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Cell motility within central nervous system (CNS) neuropil may be largely restricted yet infiltration by glioma cells is commonly observed. Glioma cells remodel nervous tissue and may assemble extracellular matrix in order to migrate. We examined the rat C6 glioma cell line for laminin expression and response in vitro and following engraftment into rat spinal cord. C6 cell cultures expressed laminin-2. C6 cells attached equally well to substrates of purified laminin-1 and laminin-2 and laminin-2-enriched C6 conditioned medium. In contrast, C6 cell migration was substantially greater on laminin-2 and C6-derived substrata than on laminin-1. Glioma cell attachment to laminin-1 and -2 was largely inhibited by antibody to the laminin receptor LBP110 and by an IKVAV peptide but not by YIGSR or control peptides. IKVAV peptide and anti-LBP110 antibodies also inhibited glioma cell invasion through synthetic basement membrane. Anti-β1 integrin antibody selectively inhibited cell migration and invasion on laminin-2 substrata without affecting percent cell attachment. These findings suggest C6 cell migration and invasion are promoted by autocrine release of laminin-2 and involve LPB110 and β1 integrin laminin receptors. A possible role for laminin-2 in CNS infiltration in vivo was examined following glioma engraftment into rat spinal cord. Engrafted C6 tumors share many histologic features of invasive human glioma. Engrafted glioma cells expressed laminin, LBP110 and β1 integrin antigens, indicating the molecular mechanisms of C6 motility observed in culture may contribute to glioma invasion in vivo. NMR and corroborative immunocytochemistry provided precise means to monitor tumor progression following glioma engraftment into rat spinal cord. Advantages of this glioma model are discussed regarding the assessment of anti-adhesive therapies in vivo.

Original languageEnglish (US)
Pages (from-to)199-211
Number of pages13
JournalJournal of Neuro-Oncology
Volume30
Issue number3
DOIs
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Laminin
Glioma
Spinal Cord
Neoplasms
isoleucyl-lysyl-valyl-alanyl-valine
Cell Movement
Integrins
Laminin Receptors
tyrosyl-isoleucyl-glycyl-seryl-arginine
Peptides
In Vitro Techniques
Central Nervous System
Nerve Tissue
Neuropil
Antibodies
Conditioned Culture Medium
Basement Membrane
Adhesives
Extracellular Matrix
Anti-Idiotypic Antibodies

Keywords

  • C6 glioma
  • Invasion
  • Laminin
  • Migration
  • NMR
  • Peptide antagonist
  • Spinal cord

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

Assessment of laminin-mediated glioma invasion in vitro and by glioma tumors engrafted within rat spinal cord. / Muir, David; Johnson, Jennifer; Rojiani, Mumtaz V; Inglis, Ben A.; Rojiani, Amyn Mohammed; Maria, Bernard L.

In: Journal of Neuro-Oncology, Vol. 30, No. 3, 01.01.1996, p. 199-211.

Research output: Contribution to journalArticle

@article{be5cf98e99f84ffca1fea970e40d9560,
title = "Assessment of laminin-mediated glioma invasion in vitro and by glioma tumors engrafted within rat spinal cord",
abstract = "Cell motility within central nervous system (CNS) neuropil may be largely restricted yet infiltration by glioma cells is commonly observed. Glioma cells remodel nervous tissue and may assemble extracellular matrix in order to migrate. We examined the rat C6 glioma cell line for laminin expression and response in vitro and following engraftment into rat spinal cord. C6 cell cultures expressed laminin-2. C6 cells attached equally well to substrates of purified laminin-1 and laminin-2 and laminin-2-enriched C6 conditioned medium. In contrast, C6 cell migration was substantially greater on laminin-2 and C6-derived substrata than on laminin-1. Glioma cell attachment to laminin-1 and -2 was largely inhibited by antibody to the laminin receptor LBP110 and by an IKVAV peptide but not by YIGSR or control peptides. IKVAV peptide and anti-LBP110 antibodies also inhibited glioma cell invasion through synthetic basement membrane. Anti-β1 integrin antibody selectively inhibited cell migration and invasion on laminin-2 substrata without affecting percent cell attachment. These findings suggest C6 cell migration and invasion are promoted by autocrine release of laminin-2 and involve LPB110 and β1 integrin laminin receptors. A possible role for laminin-2 in CNS infiltration in vivo was examined following glioma engraftment into rat spinal cord. Engrafted C6 tumors share many histologic features of invasive human glioma. Engrafted glioma cells expressed laminin, LBP110 and β1 integrin antigens, indicating the molecular mechanisms of C6 motility observed in culture may contribute to glioma invasion in vivo. NMR and corroborative immunocytochemistry provided precise means to monitor tumor progression following glioma engraftment into rat spinal cord. Advantages of this glioma model are discussed regarding the assessment of anti-adhesive therapies in vivo.",
keywords = "C6 glioma, Invasion, Laminin, Migration, NMR, Peptide antagonist, Spinal cord",
author = "David Muir and Jennifer Johnson and Rojiani, {Mumtaz V} and Inglis, {Ben A.} and Rojiani, {Amyn Mohammed} and Maria, {Bernard L.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1007/BF00177271",
language = "English (US)",
volume = "30",
pages = "199--211",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Assessment of laminin-mediated glioma invasion in vitro and by glioma tumors engrafted within rat spinal cord

AU - Muir, David

AU - Johnson, Jennifer

AU - Rojiani, Mumtaz V

AU - Inglis, Ben A.

AU - Rojiani, Amyn Mohammed

AU - Maria, Bernard L.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Cell motility within central nervous system (CNS) neuropil may be largely restricted yet infiltration by glioma cells is commonly observed. Glioma cells remodel nervous tissue and may assemble extracellular matrix in order to migrate. We examined the rat C6 glioma cell line for laminin expression and response in vitro and following engraftment into rat spinal cord. C6 cell cultures expressed laminin-2. C6 cells attached equally well to substrates of purified laminin-1 and laminin-2 and laminin-2-enriched C6 conditioned medium. In contrast, C6 cell migration was substantially greater on laminin-2 and C6-derived substrata than on laminin-1. Glioma cell attachment to laminin-1 and -2 was largely inhibited by antibody to the laminin receptor LBP110 and by an IKVAV peptide but not by YIGSR or control peptides. IKVAV peptide and anti-LBP110 antibodies also inhibited glioma cell invasion through synthetic basement membrane. Anti-β1 integrin antibody selectively inhibited cell migration and invasion on laminin-2 substrata without affecting percent cell attachment. These findings suggest C6 cell migration and invasion are promoted by autocrine release of laminin-2 and involve LPB110 and β1 integrin laminin receptors. A possible role for laminin-2 in CNS infiltration in vivo was examined following glioma engraftment into rat spinal cord. Engrafted C6 tumors share many histologic features of invasive human glioma. Engrafted glioma cells expressed laminin, LBP110 and β1 integrin antigens, indicating the molecular mechanisms of C6 motility observed in culture may contribute to glioma invasion in vivo. NMR and corroborative immunocytochemistry provided precise means to monitor tumor progression following glioma engraftment into rat spinal cord. Advantages of this glioma model are discussed regarding the assessment of anti-adhesive therapies in vivo.

AB - Cell motility within central nervous system (CNS) neuropil may be largely restricted yet infiltration by glioma cells is commonly observed. Glioma cells remodel nervous tissue and may assemble extracellular matrix in order to migrate. We examined the rat C6 glioma cell line for laminin expression and response in vitro and following engraftment into rat spinal cord. C6 cell cultures expressed laminin-2. C6 cells attached equally well to substrates of purified laminin-1 and laminin-2 and laminin-2-enriched C6 conditioned medium. In contrast, C6 cell migration was substantially greater on laminin-2 and C6-derived substrata than on laminin-1. Glioma cell attachment to laminin-1 and -2 was largely inhibited by antibody to the laminin receptor LBP110 and by an IKVAV peptide but not by YIGSR or control peptides. IKVAV peptide and anti-LBP110 antibodies also inhibited glioma cell invasion through synthetic basement membrane. Anti-β1 integrin antibody selectively inhibited cell migration and invasion on laminin-2 substrata without affecting percent cell attachment. These findings suggest C6 cell migration and invasion are promoted by autocrine release of laminin-2 and involve LPB110 and β1 integrin laminin receptors. A possible role for laminin-2 in CNS infiltration in vivo was examined following glioma engraftment into rat spinal cord. Engrafted C6 tumors share many histologic features of invasive human glioma. Engrafted glioma cells expressed laminin, LBP110 and β1 integrin antigens, indicating the molecular mechanisms of C6 motility observed in culture may contribute to glioma invasion in vivo. NMR and corroborative immunocytochemistry provided precise means to monitor tumor progression following glioma engraftment into rat spinal cord. Advantages of this glioma model are discussed regarding the assessment of anti-adhesive therapies in vivo.

KW - C6 glioma

KW - Invasion

KW - Laminin

KW - Migration

KW - NMR

KW - Peptide antagonist

KW - Spinal cord

UR - http://www.scopus.com/inward/record.url?scp=0029960443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029960443&partnerID=8YFLogxK

U2 - 10.1007/BF00177271

DO - 10.1007/BF00177271

M3 - Article

C2 - 8943095

AN - SCOPUS:0029960443

VL - 30

SP - 199

EP - 211

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -